SCHEMBL8900065

SCHEMBL8900065

COC(C)Oc1cccc2c(N)nc(NCC3CCC(CN)CC3)nc12

nearest known ligand 0.43

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
NPY5R Q15761 9/20 0.43
MCHR1 Q99705 5/20 0.43
ADRA2A P08913 3/20 0.43
AQP1 P29972 2/20 0.43
ALDH1A1 P00352 1/20 0.43
MAPT P10636 1/20 0.43
HPGD P15428 1/20 0.43
NPY1R P25929 1/20 0.43
NPY2R P49146 1/20 0.43
NPY4R P50391 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
SLC6A4 P31645 2/20 0.39
PRKCQ Q04759 4/20 0.37
IDH1 O75874 1/20 0.34
IDH2 P48735 1/20 0.34
CD38 P28907 1/20 0.34
BCDIN3D Q7Z5W3 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8900115 0.88 NPY5R (0.46) NPY5RMCHR1ADRA2AAQP1ALDH1A1
Hydrochloric Acid SCHEMBL8899118 0.87 NPY5R (0.45) NPY5RMCHR1ADRA2AAQP1ALDH1A1
SCHEMBL8890893 0.80 NPY5R (0.44) NPY5RMCHR1ADRA2AAQP1ALDH1A1
SCHEMBL8891562 0.80 NPY5R (0.46) NPY5RMCHR1ADRA2AAQP1ALDH1A1
SCHEMBL8898927 0.78 NPY5R (0.49) NPY5RMCHR1ADRA2AAQP1ALDH1A1
SCHEMBL8898901 0.78 NPY5R (0.49) NPY5RMCHR1ADRA2AAQP1ALDH1A1
SCHEMBL8891551 0.76 VCP (0.54) NPY5RMCHR1ADRA2AAQP1ALDH1A1
Hydrochloric Acid SCHEMBL8899106 0.75 VCP (0.53) NPY5RMCHR1ADRA2AAQP1ALDH1A1
SCHEMBL8901221 0.74 DCPS (0.51) NPY5RMCHR1ADRA2AAQP1ALDH1A1
SCHEMBL8891992 0.74 PRKCQ (0.41) NPY5RMCHR1ADRA2AAQP1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1997020823-A2 2-AMINO QUINAZOLINE DERIVATIVES AS NPY RECEPTOR ANTAGONISTS NOVARTIS AG (CH) 1997-06-12 WO disclosed